A new generation of compounds for the treatment for diabetes type 2
Short facts:
- Bengtssons’s research group at Stockholm University is investigating how novel adrenergic signaling stimulates glucose uptake in tissues
- Atrogi AB, a company that develops drugs against metabolic disorders such as type 2 diabetes